A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Trial Centre Location Province Status
Cross Cancer Institute Edmonton Alberta Closed
Tom Baker Cancer Centre Calgary Alberta Closed
BC Cancer Agency - Centre for the Southern Interior Kelowna British Columbia Closed
QEII Health Sciences Centre Halifax Nova Scotia Closed
Hamilton Health Sciences Hamilton Ontario Closed
North York General Hospital Toronto Ontario Closed
Princess Margaret Cancer Centre Toronto Ontario Closed
Sunnybrook Health Sciences Centre Toronto Ontario Closed
The Ottawa Hospital Ottawa Ontario Closed
CHU de Québec - Université Laval - L'Hôtel-Dieu de Québec Quebec Quebec Closed
CIUSSS de l'Estrie - Centre hospitalier universitaire de Sherbrooke Sherbrooke Quebec Closed
MUHC Glen site Montreal Quebec Closed

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society